On average, patients experience an 8-10% reduction in body weight, though individual results may vary
While randomized controlled trials (RCTs) established the efficacy and general safety of these agents, RCT protocols often underrepresent real-world patient complexity, heterogeneous comorbidities, and long-term adherence barriers
Monitor for increased nausea, vomiting, constipation, appetite loss, and digestive discomforteffects that may feel amplified when both medications are active
Continue your existing nodule surveillance schedule as recommended by your endocrinologist, regardless of tirzepatide use
BPC 157 largely interacts with the dopamine system (a topic reviewed specifically elsewhere [8,12]) since BPC 157 counteracts various disturbances, tremors, akinesias, and catalepsies that appear within the dopamine system disability [26,30,51,52,54,55,56,57]
The CASTOR proteins are arginine sensors for the mTORC1 pathway